| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Institut für Kardiovaskuläre Physiologie (K.K., R.B., I.F.), and Institut für Biochemie II (F.S., W.M.-E.), Klinikum der J.W.G.-Universität, Frankfurt am Main, Germany.
Correspondence to Ingrid Fleming, PhD, Institut für Kardiovaskuläre Physiologie, Klinikum der J.W.G.-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany. E-mail fleming{at}em.uni-frankfurt.de
Soluble angiotensin-converting enzyme (ACE) is derived from the membrane-bound form by proteolytic cleavage of its C-terminal domain. Because intracellular events might be involved in the regulation of the cleavage process, we determined whether the cytoplasmic tail of ACE is phosphorylated and whether this process regulates secretion. Immunoprecipitation of ACE (180 kDa) from 32P-labeled endothelial cells revealed that ACE is phosphorylated. Phosphorylation was not observed in endothelial cells overexpressing a mutant form of ACE (ACE
S, all five cytoplasmic serine residues replaced by alanine). CK2 coprecipitated with ACE from endothelial cells, and CK2 phosphorylated both ACE and a peptide corresponding to the cytoplasmic tail. Mutation of serine1270 within the CK2 consensus sequence almost abolished ACE phosphorylation. In ACE-overexpressing endothelial cells, ACE was mostly localized to the plasma membrane. However, no ACE was detected in the plasma membrane of ACE
S-overexpressing cells, although a precursor ACE (170 kDa) was prominent in the endoplasmic reticulum and the cell supernatant contained substantial amounts of the soluble protein (175 kDa). A correlation between ACE-phosphorylation and secretion was confirmed in endothelial cells treated with the CK2-inhibitor, 5,6-dichloro-1-ß-D-ribofuranosylbenzimidazole, which time-dependently decreased the phosphorylation of ACE and increased its shedding. These results indicate that the CK2-mediated phosphorylation of ACE regulates its retention in the plasma membrane and may determine plasma ACE levels.
Key Words: angiotensin-converting enzyme casein kinase 2 phosphorylation protein cleavage ACE secretase
This article has been cited by other articles:
![]() |
K. Kohlstedt, C. Gershome, C. Trouvain, W.-K. Hofmann, S. Fichtlscherer, and I. Fleming Angiotensin-Converting Enzyme (ACE) Inhibitors Modulate Cellular Retinol-Binding Protein 1 and Adiponectin Expression in Adipocytes via the ACE-Dependent Signaling Cascade Mol. Pharmacol., March 1, 2009; 75(3): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Widder, W. Chen, L. Li, S. Dikalov, B. Thony, K. Hatakeyama, and D. G. Harrison Regulation of Tetrahydrobiopterin Biosynthesis by Shear Stress Circ. Res., October 12, 2007; 101(8): 830 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Strauss and A. S. Hall Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox Circulation, August 22, 2006; 114(8): 838 - 854. [Full Text] [PDF] |
||||
![]() |
M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kohlstedt, C. Gershome, M. Friedrich, W. Muller-Esterl, F. Alhenc-Gelas, R. Busse, and I. Fleming Angiotensin-Converting Enzyme (ACE) Dimerization Is the Initial Step in the ACE Inhibitor-Induced ACE Signaling Cascade in Endothelial Cells Mol. Pharmacol., May 1, 2006; 69(5): 1725 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming Signaling by the Angiotensin-Converting Enzyme Circ. Res., April 14, 2006; 98(7): 887 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. K. Leong, A. Devillez, M. B. Sandberg, L. E. Yang, D. K. P. Yip, J. B. Klein, and A. A. McDonough Effects of ACE inhibition on proximal tubule sodium transport Am J Physiol Renal Physiol, April 1, 2006; 290(4): F854 - F863. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kohlstedt, R. Kellner, R. Busse, and I. Fleming Signaling via the Angiotensin-Converting Enzyme Results in the Phosphorylation of the Nonmuscle Myosin Heavy Chain IIA Mol. Pharmacol., January 1, 2006; 69(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Warner, R. A. Lew, A. I. Smith, D. W. Lambert, N. M. Hooper, and A. J. Turner Angiotensin-converting Enzyme 2 (ACE2), But Not ACE, Is Preferentially Localized to the Apical Surface of Polarized Kidney Cells J. Biol. Chem., November 25, 2005; 280(47): 39353 - 39362. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Carretero Novel mechanism of action of ACE and its inhibitors Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1796 - H1797. [Full Text] [PDF] |
||||
![]() |
V. Thimon, S. Metayer, M. Belghazi, F. Dacheux, J.-L. Dacheux, and J.-L. Gatti Shedding of the Germinal Angiotensin I-Converting Enzyme (gACE) Involves a Serine Protease and Is Activated by Epididymal Fluid Biol Reprod, November 1, 2005; 73(5): 881 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chattopadhyay, K. R. Santhamma, S. Sengupta, B. McCue, M. Kinter, G. C. Sen, and I. Sen Calmodulin Binds to the Cytoplasmic Domain of Angiotensin-converting Enzyme and Regulates Its Phosphorylation and Cleavage Secretion J. Biol. Chem., October 7, 2005; 280(40): 33847 - 33855. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming, K. Kohlstedt, and R. Busse New fACEs to the Renin-Angiotensin System Physiology, April 1, 2005; 20(2): 91 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Dean, J. Tan, E. R. O'Brien, and F. H. H. Leenen 17{beta}-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R759 - R766. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kohlstedt, R. Busse, and I. Fleming Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells Hypertension, January 1, 2005; 45(1): 126 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Tsakadze, U. Sen, Z. Zhao, S. D. Sithu, W. R. English, and S. E. D'Souza Signals mediating cleavage of intercellular adhesion molecule-1 Am J Physiol Cell Physiol, July 1, 2004; 287(1): C55 - C63. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan and C. D. Sigmund ACE, ACE Inhibitors, and Other JNK Circ. Res., January 9, 2004; 94(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
K. Kohlstedt, R. P. Brandes, W. Muller-Esterl, R. Busse, and I. Fleming Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells Circ. Res., January 9, 2004; 94(1): 60 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Parkin, F. Tan, R. A. Skidgel, A. J. Turner, and N. M. Hooper The ectodomain shedding of angiotensin-converting enzyme is independent of its localisation in lipid rafts J. Cell Sci., August 1, 2003; 116(15): 3079 - 3087. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |